|
1
|
Cowan RW and Singh G: Giant cell tumor of
bone: A basic science perspective. Bone. 52:238–246. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nishimura M, Yuasa K, Mori K, Miyamoto N,
Ito M, Tsurudome M, Nishio M, Kawano M, Komada H, Uchida A and Ito
Y: Cytological properties of stromal cells derived from giant cell
tumor of bone (GCTSC) which can induce osteoclast formation of
human blood monocytes without cell to cell contact. J Orthop Res.
23:979–987. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siddiqui MA, Seng C and Tan MH: Risk
factors for recurrence of giant cell tumours of bone. J OrthopSurg
(Hong Kong). 22:108–110. 2014. View Article : Google Scholar
|
|
4
|
van der Heijden L, Dijkstra PD, van de
Sande MA, Kroep JR, Nout RA, van Rijswijk CS, Bovée JV, Hogendoorn
PC and Gelderblom H: The clinical approach toward giant cell tumor
of bone. Oncologist. 19:550–561. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hu P, Zhao L, Zhang H, Yu X, Wang Z, Ye Z,
Wu S, Guo S, Zhang G, Wang J, et al: Recurrence rates and risk
factors for primary giant cell tumors around the knee: A
multicentre retrospective study in china. Sci Rep. 6:363322016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zambo I and Vesely K: WHO classification
of tumours of soft tissue and bone 2013: The main changes compared
to the 3rd edition. Cesk Patol. 50:64–70. 2014.(In Czech).
PubMed/NCBI
|
|
7
|
Enneking WF: A system of staging
musculoskeletal neoplasms. Clin Orthop Relat Res. 9–24.
1986.PubMed/NCBI
|
|
8
|
Wülling M, Engels C, Jesse N, Werner M,
Delling G and Kaiser E: The nature of giant cell tumor of bone. J
Cancer Res Clin Oncol. 127:467–474. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Klenke FM, Wenger DE, Inwards CY, Rose PS
and Sim FH: Giant cell tumor of bone: Risk factors for recurrence.
Clin Orthop Relat Res. 469:591–599. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arbeitsgemeinschaft Knochentumoren, ;
Becker WT, Dohle J, Bernd L, Braun A, Cserhati M, Enderle A, Hovy
L, Matejovsky Z, Szendroi M, et al: Local recurrence of giant cell
tumor of bone after intralesional treatment with and without
adjuvant therapy. J Bone Joint Surg Am. 90:1060–1067. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Masui F, Ushigome S and Fujii K: Giant
cell tumor of bone: An immunohistochemical comparative study.
Pathol Int. 48:355–361. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu Z, Yin H, Liu T, Yan W, Li Z, Chen J,
Chen H, Wang T, Jiang Z, Zhou W and Xiao J: MiR-126-5p regulates
osteoclast differentiation and bone resorption in giant cell tumor
through inhibition of MMP-13. Biochem Biophys Res Commun.
443:944–949. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kumta SM, Huang L, Cheng YY, Chow LT, Lee
KM and Zheng MH: Expression of VEGF and MMP-9 in giant cell tumor
of bone and other osteolytic lesions. Life Sci. 73:1427–1436. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Quattrini I, Pollino S, Pazzaglia L, Conti
A, Novello C, Ferrari C, Pignotti E, Picci P and Benassi MS:
Prognostic role of nuclear factor/IB and bone remodeling proteins
in metastatic giant cell tumor of bone: A retrospective study. J
Orthop Res. 33:1205–1211. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang T, Zhang G, Lau CP, Zheng LZ, Xie XH,
Wang XL, Wang XH, He K, Patrick Y, Qin L and Kumta SM: Effect of
water-soluble P-chitosan and S-chitosan on human primary
osteoblasts and giant cell tumor of bone stromal cells. Biomed
Mater. 6:0150042011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang CS, Lou JH, Liao JS, Liao JS, Ding
XY, Du LJ, Lu Y, Yan L and Chen KM: Recurrence in giant cell tumour
of bone: Imaging features and risk factors. Radiol Med.
118:456–464. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen L, Ding XY, Wang CS, Si MJ, Du LJ,
Zhang WB and Lu Y: In-depth analysis of local recurrence of giant
cell tumour of bone with soft tissue extension after intralesional
curettage. Radiol Med. 119:861–870. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Klenke FM, Wenger DE, Inwards CY, Rose PS
and Sim FH: Recurrent giant cell tumor of long bones: Analysis of
surgical management. Clin Orthop Relat Res. 469:1181–1187. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Prosser GH, Baloch KG, Tillman RM, Carter
SR and Grimer RJ: Does curettage without adjuvant therapy provide
low recurrence rates in giant-cell tumors of bone? Clin Orthop
Relat Res. 211–218. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang H, Wan N and Hu Y: Giant cell tumour
of bone: A new evaluating system is necessary. Int Orthop.
36:2521–2527. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
de Moraes M, de Matos FR, de Souza LB, de
Almeida Freitas R and de Lisboa Lopes Costa A: Immunoexpression of
RANK RANKL, OPG, VEGF and vWF in radicular and dentigerous cysts. J
Oral Pathol Med. 42:468–473. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kanematsu M, Semelka RC, Leonardou P,
Mastropasqua M, Armao D, Vaidean G, Firat Z and Woosley JT:
Angiogenesis in hepatocellular nodules: Correlation of MR imaging
and vascular endothelial growth factor. J Magn Reson Imaging.
20:426–434. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He Y, Zhang J and Ding X: Prognosis of
local recurrence in giant cell tumour of bone: What can we do?
Radiol Med. 122:505–519. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chambers AF and Matrisian LM: Changing
views of the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reponen P, Sahlberg C, Munaut C, Thesleff
I and Tryggvason K: High expression of 92-kD type IV collagenase
(gelatinase B) in the osteoclast lineage during mouse development.
J Cell Biol. 124:1091–1102. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lynch CC and Matrisian LM: Matrix
metalloproteinases in tumor-host cell communication.
Differentiation. 70:561–573. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen KW, Yang HL, Lu J, Wang GL, Ji YM, Wu
GZ, Zhu LF, Liu JY, Chen XQ and Gu YP: Expression of vascular
endothelial growth factor and matrix metalloproteinase-9 in sacral
chordoma. J Neurooncol. 101:357–363. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kaya M, Wada T, Kawaguchi S, Nagoya S,
Yamashita T, Abe Y, Hiraga H, Isu K, Shindoh M, Higashino F, et al:
Increased pre-therapeutic serum vascular endothelial growth factor
in patients with early clinical relapse of osteosarcoma. Br J
Cancer. 86:864–869. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shuman Moss LA, Jensen-Taubman S and
Stetler-Stevenson WG: Matrix metalloproteinases: Changing roles in
tumor progression and metastasis. Am J Pathol. 181:1895–1899. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chawla S, Henshaw R, Seeger L, Choy E,
Blay JY, Ferrari S, Kroep J, Grimer R, Reichardt P, Rutkowski P, et
al: Safety and efficacy of denosumab for adults and skeletally
mature adolescents with giant cell tumour of bone: Interim analysis
of an open-label, parallel-group, phase 2 study. Lancet Oncol.
14:901–908. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu CX, Lin GS, Lin ZX, Zhang JD, Chen L,
Liu SY, Tang WL, Qiu XX and Zhou CF: Peritumoral edema on magnetic
resonance imaging predicts a poor clinical outcome in malignant
glioma. Oncol Lett. 10:2769–2776. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
O'Donnell RJ, Springfield DS, Motwani HK,
Ready JE, Gebhardt MC and Mankin HJ: Recurrence of giant-cell
tumors of the long bones after curettage and packing with cement. J
Bone Joint Surg Am. 76:1827–1833. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Scully SP, Mott MP, Temple HT, O'Keefe RJ,
O'Donnell RJ and Mankin HJ: Late recurrence of giant-cell tumor of
bone. A report of four cases. J Bone Joint Surg Am. 76:1231–1233.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lausten GS, Jensen PK, Schiodt T and Lund
B: Local recurrences in giant cell tumour of bone. Long-term follow
up of 31 cases. Int Orthop. 20:172–176. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kivioja AH, Blomqvist C, Hietaniemi K,
Trovik C, Walloe A, Bauer HC, Jorgensen PH, Bergh P and Follerås G:
Cement is recommended in intralesional surgery of giant cell
tumors: A Scandinavian Sarcoma Group study of 294 patients followed
for a median time of 5 years. Acta Orthop. 79:86–93. 2008.
View Article : Google Scholar : PubMed/NCBI
|
